ACRS Aclaris Therapeutics, Inc. logo

ACRS Aclaris Therapeutics, Inc.

Healthcare
$4.51-0.22%ClosedMarket Cap: $543.9M

As of 2026-05-26

Insider Statistics (Q1 2026)

Acquisitions

25

Dispositions

23

Buy/Sell Ratio

1.09

Net Shares

+3,356,222

Shares Acquired

3,670,075

Shares Disposed

313,853

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue May 05Hall Jesse Wayneofficer: Chief Medical OfficerSell36,375$0.00109,125
Tue May 05Hall Jesse Wayneofficer: Chief Medical OfficerSell9,330$4.4127,045
Mon Apr 27Leonard Braden Michael10 percent ownerSell300,000$4.5313,950,000
Tue Mar 03Balthaser Kevinofficer: Chief Financial OfficerSell2,375$0.00188,130
Tue Mar 03Balthaser Kevinofficer: Chief Financial OfficerSell677$2.87187,453
Fri Feb 06Walker Nealdirector, officer: CEOSell961,700$3.61961,700
Fri Feb 06Walker Nealdirector, officer: CEOSell274,800$0.00274,800
Fri Feb 06Kolbeck Roland Wilhelmofficer: Chief Scientific OfficerSell334,900$3.61334,900
Fri Feb 06Kolbeck Roland Wilhelmofficer: Chief Scientific OfficerSell95,700$0.0095,700
Fri Feb 06Hall Jesse Wayneofficer: Chief Medical OfficerSell343,300$3.61343,300
Fri Feb 06Davis Hugh M.director, officer: President and COOSell336,300$3.61336,300
Fri Feb 06Davis Hugh M.director, officer: President and COOSell96,100$0.0096,100